Indian share markets ended their trading session lower yesterday.
Benchmark indices edged lower tracking weak global cues as investors fretted over weak economic data and rising COVID-19 cases.
Barring energy stocks, all sectoral indices ended on a negative note with stocks in the power sector, telecom sector and consumer durables sector witnessing most of the selling pressure.
At the closing bell yesterday, the BSE Sensex stood lower by 242 points and the NSE Nifty closed down by 72 points.
The SGX Nifty was trading at 9,200, down by 53 points, at the time of writing.
The BSE Mid Cap index and the BSE Small Cap index ended their day down by 0.5% and 0.1%, respectively.
Speaking of the current stock market scenario, after a sharp rally in the past few weeks, the markets have turned volatile again.
You would be interested in knowing when the market will likely bottom out.
Vijay Bhambwani, editor of Weekly Cash Alerts, has the answer and he has recorded a video about it.
You can check the same here - This is When the Stock Market Will Bottom Out
Also, our special report, How to Trade the Coronavirus Crash, is the most comprehensive report on how to trade the coronavirus, both from a short-term and long-term perspective. You can claim your FREE copy here...
From the pharma sector, Dr Reddy's Laboratories share price will be in focus as the company announced that the its NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been approved by the US Food and Drug Administration.
The drug is indicated for the acute treatment of migraine with or without aura in adults.
From the IT sector, HCL Technologies share price will also be in focus as the company reported a 22.8% year-on-year (YoY) rise in consolidated net profit at Rs 31.5 billion compared with Rs 25.7 billion in the same quarter last year.
Revenue for the quarter rose 16.3% YoY to Rs 185.9 billion from Rs 159.9 billion reported in the year-ago quarter. In dollar terms, revenue rose 11.7% YoY to US$ 2,543.40 million from US$ 2,277.80 million. On a sequential basis, dollar sales were flat. Sales growth in constant currency terms rose 13.5% YoY to US$ 2,584.60 million.
To know more about the company, you can read HCL Technologies' Q4FY20 result analysis on our website.
Market participants will also be tracking RBL Bank share price, Cyient share price and Gillette share price as these companies announced their March quarter results yesterday.
You can read our recently released Q4FY20 results of other companies here: Ambuja Cement, IndusInd Bank, Axis Bank, Tech Mahindra, HUL, Reliance Industries, Marico, Kansai Nerolac, NIIT Technologies, Persistent Systems.
From the FMCG sector, Hindustan Unilever (HUL) share price will be in focus as the UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals yesterday.
According to the term sheet, over 133 million shares are being offered in the range of Rs 1,850-1,950 to investors through a special block window. The deal will be valued roughly between Rs 246 billion to Rs 259 billion.
GSK and Horlicks are selling up to US$ 3.4 billion worth of HUL shares through what could be India's biggest secondary market block trades.
The British drug maker is looking to monetise about 5.7% of HUL stock it had got after last year's merger of GSK Consumer Healthcare and HUL.
As per the scheme of amalgamation amongst GSK Consumer Healthcare and HUL, GlaxoSmithKline Pte had received 54.08 million shares of HUL, meanwhile Horlicks received 79.69 million shares.
Accordingly, parent company Unilever Plc and group companies' stake in HUL reduced to 61.9%, from 67.2% earlier after the issue of new shares.
Yes Bank reported better-than-expected March quarter (Q4FY20) results.
Yes Bank posted a net profit of Rs 26.3 billion on the back of one-time gain attributed to an exceptional item of Rs 63 billion.
The bank has written-down additional tier-1 bonds as part of its planned reconstruction scheme, leading to a one-time gain of Rs 63 billion.
In the absence of the exceptional gain, the bank would have reported a net loss of Rs 36.7 billion.
The bank had reported a net loss of Rs 15.1 billion a year ago, while the same was Rs 185.6 billion in Q3FY20.
The bank's net interest income (NII) for the March quarter came in at Rs 12.7 billion, up 19.6% sequentially.
Net interest margin (NIM) for Q4FY20 came in at 1.9%, compared to 3.1% a year ago.
On the asset quality front, gross non-performing assets (NPA) fell 19% QoQ to Rs 328.8 billion, mostly on account of write-offs.
The bank's deposits plunged to Rs 1.05 lakh crore, down 54% YoY compared with Rs 2.27 lakh crore.
Meanwhile, Advances declined 29% YoY to Rs 1.7 lakh crore from Rs 2.4 lakh crore in the year-ago quarter.
For the financial year 2019-20 (FY20), the private lender posted a loss of Rs 164.2 billion, on a standalone basis, compared to net profit of Rs 17.2 billion in the previous year.
To know more, you can read Yes Bank's latest result analysis on our website.
Speaking of the banking sector, the low access to credit for micro small and medium enterprises (MSMEs) tells us there is a huge opportunity for lenders.
This is evident from the chart below:
Of the 60 million MSMEs in India, only 11% had access to credit from organised lenders. Most of them are self-financed or get credit from unorganised sources.
Here's what Tanushree Banerjee wrote about this in one of the editions of The 5 Minute WrapUp...
Tanushree is counting on 7 top stocks from the Indian stock market that will benefit from this megatrend.
As per her, now is the right time to buy these stocks to profit from the Rebirth of India. You can read about them here.
And to know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Ends Lower, Yes Bank Q4 Results, HUL Block Deal, and Top Stocks in Focus Today". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!